Published in Am J Gastroenterol on February 01, 2001
Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43
Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol (2010) 1.96
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol (2014) 1.09
Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer (2010) 0.98
Clinical value of Helicobacter pylori stool antigen test, ImmunoCard STAT HpSA, for detecting H pylori infection. World J Gastroenterol (2004) 0.98
Application of stool-PCR test for diagnosis of Helicobacter pylori infection in children. World J Gastroenterol (2009) 0.95
Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study. World J Gastroenterol (2006) 0.93
Enzyme-linked immunosorbent assay for Helicobacter pylori needs adjustment for the population investigated. J Clin Microbiol (2004) 0.92
Bacterial urease and its role in long-lasting human diseases. Curr Protein Pept Sci (2012) 0.88
Non-invasive diagnosis of H pylori infection: evaluation of serological tests with and without current infection marker CIM. World J Gastroenterol (2008) 0.87
Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer (2008) 0.85
Diagnosis of Helicobacter spp. infection in canine stomach. J Vet Sci (2007) 0.85
Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection. Clin Vaccine Immunol (2008) 0.84
Magnetic immuno-PCR assay with inhibitor removal for direct detection of Helicobacter pylori in human feces. J Clin Microbiol (2001) 0.84
Evaluation of an Iranian Home-made Helicobacter pylori Stool Antigen ELISA Kit. Jundishapur J Microbiol (2014) 0.80
Environmental factors, seven GWAS-identified susceptibility loci, and risk of gastric cancer and its precursors in a Chinese population. Cancer Med (2017) 0.78
How labile is gastric infection with H pylori? World J Gastroenterol (2007) 0.78
Detection and clarithromycin susceptibility testing of Helicobacter pylori in stool specimens by real-time PCR: how to get accurate test results. J Clin Microbiol (2007) 0.78
Diagnostic performance of gastric imprint smear for determination of Helicobacter pylori infection. Can J Gastroenterol (2010) 0.76
Normalized real-time PCR for diagnosis of H. pylori infection. Qatar Med J (2014) 0.75
The diagnostic accuracy of rapid urease biopsy test compared to histopathology in implementing "test and treat" policy for Helicobacter pylori. Int J Appl Basic Med Res (2016) 0.75
First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic. Ulus Cerrahi Derg (2014) 0.75
Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol (2011) 0.75
Diagnosis of Helicobacter pylori: Changes towards the Future. Diseases (2015) 0.75
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. J Clin Microbiol (1985) 4.93
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer (1984) 3.94
p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem (1999) 3.90
Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol (1997) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother (1997) 3.27
Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J (1999) 3.17
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut (2001) 2.62
Molecular cloning of the receptor for human antidiuretic hormone. Nature (1992) 2.44
Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother (1986) 2.26
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2001) 2.10
Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol (1998) 2.02
In vitro model for Campylobacter pylori adherence properties. Infect Immun (1988) 1.97
Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev (1999) 1.92
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther (2003) 1.76
Matrix-assisted laser-desorption/ionization biotyper: experience in the routine of a University hospital. Clin Microbiol Infect (2011) 1.74
Helicobacter pylori and duodenal ulcer. Evidence suggesting causation. Dig Dis Sci (1992) 1.73
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol (2000) 1.68
Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2000) 1.67
The gene encoding L1, a neural adhesion molecule of the immunoglobulin family, is located on the X chromosome in mouse and man. Genomics (1990) 1.67
Cefotaxime-hydrolysing beta lactamases in Morganella morganii. Eur J Clin Microbiol Infect Dis (1999) 1.67
Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut (1985) 1.64
Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut (2001) 1.62
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother (2001) 1.60
Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59
GC content of DNA of Campylobacter pylori and other species belonging or related to the genus Campylobacter. Ann Inst Pasteur Microbiol (1989) 1.54
Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep (2001) 1.52
Laboratory-acquired Helicobacter pylori infection. Lancet (1995) 1.49
Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther (2003) 1.49
Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res (1988) 1.46
Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 1.46
Truncus arteriosus repair: influence of techniques of right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg (1996) 1.46
Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol (2012) 1.45
Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer (2000) 1.44
Development of a real-time fluorescence resonance energy transfer PCR to identify the main pathogenic Campylobacter spp. Clin Microbiol Infect (2005) 1.43
Haemophilus species in the human gastrointestinal tract. Eur J Clin Microbiol Infect Dis (1988) 1.42
Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.42
[CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study]. Gastroenterol Clin Biol (2001) 1.42
[Necrotizing amebic colitis]. Gastroenterol Clin Biol (1994) 1.40
Optimal pacing in congenital complete atrioventricular block of immunological origin: interest of multisite stimulation. Pacing Clin Electrophysiol (2007) 1.39
Molecular cloning and expression of a fifth muscarinic acetylcholine receptor. J Biol Chem (1989) 1.35
Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut (2005) 1.34
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut (1997) 1.31
Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother (1999) 1.30
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer (2003) 1.30
Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut (2003) 1.29
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett (1998) 1.27
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother (1985) 1.25
Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J Microbiol Methods (2001) 1.25
125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand. Eur J Pharmacol (1988) 1.25
Early amniocentesis versus chorionic villus sampling for fetal karyotyping. Lancet (1994) 1.25
Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): a prospective biopsy study. J Clin Pathol (1984) 1.24
In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother (2001) 1.24
Isolation of Campylobacter species by filtration. Eur J Clin Microbiol (1985) 1.22
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol (2002) 1.21
Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut (2006) 1.20
Identification of Campylobacter species and related organisms by matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Clin Microbiol Infect (2011) 1.19
Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob Agents Chemother (1991) 1.19
Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2001) 1.17
Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol (1997) 1.17
[Phenotype characteristics of 100 strains of Pseudomonas cepacia. Proposition of a biovars classification (author's transl)]. Ann Biol Clin (Paris) (1981) 1.15
A large multi-pathogen waterborne community outbreak linked to faecal contamination of a groundwater system, France, 2000. Clin Microbiol Infect (2006) 1.15
Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther (2009) 1.15
Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin. J Pathol (1988) 1.13
Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol (1997) 1.13
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia (2012) 1.11
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem (1995) 1.11
Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study. Aliment Pharmacol Ther (2003) 1.11
Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP). Oncogene (2001) 1.10
Evaluation of performances of three DNA enzyme immunoassays for detection of Helicobacter pylori PCR products from biopsy specimens. J Clin Microbiol (1997) 1.10
Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol (2010) 1.10
Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy. Am J Gastroenterol (1997) 1.10
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2002) 1.10
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett (1996) 1.09
Accuracy of estimation of dental treatment need in special care patients. J Dent (2000) 1.09
[Amoebic liver abscess. Study of 20 cases with literature review]. Rev Med Interne (2003) 1.08
Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut (2011) 1.08
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection. Aliment Pharmacol Ther (1999) 1.08
Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist (2002) 1.08
Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol (1999) 1.08
A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut (1995) 1.07
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06
A functional genomic study to identify differential gene expression in the preterm and term human myometrium. Biol Reprod (2003) 1.05
Microwave irradiation affects gene expression in plants. Plant Signal Behav (2006) 1.05
Pharmacological characterization of two specific binding sites for neurohypophyseal hormones in hippocampal synaptic plasma membranes of the rat. EMBO J (1985) 1.03
Differential localization of Na+/H+ exchanger isoforms (NHE1 and NHE3) in polarized epithelial cell lines. J Cell Sci (1996) 1.03
Lymphoid follicular proctitis. A condition different from ulcerative proctitis? Dig Dis Sci (1988) 1.02
Isolation of a urease positive thermophilic variant of Campylobacter lari from a patient with urinary tract infection. Eur J Clin Microbiol Infect Dis (1990) 1.01